Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kristen Ganjoo, MD
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Cancer Center
Tucson, Arizona, United States
- Sarcoma Oncology Center
Santa Monica, California, United States
- Stanford University
Stanford, California, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Washingon University Siteman Cancer Center
St Louis, Missouri, United States
- Mary Crowley Cancer Research Centers
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2008
- Primary completion
- 31 Jul 2013
- Completion
- 31 Oct 2013
- Last update posted
- 13 May 2025
- Registered enrollment
- 107
- Registry id
- NCT00742963
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.